600223.SHG Lushang Property Co Ltd
- Market cap
- CNY 5.52B
- P/E
- 36.2x
- P/B
- 1.27x
- ROE
- 3.5%
- Dividend yield
- 1.18%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600223.SHG undervalued?
Graham number600223.SHG trades 43.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Lushang Property Co Ltd fundamental analysis
No fundamental analysis for Lushang Property Co Ltd yet.
Lushang Property Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Lushang Property Co Ltd
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as …
Full company profileLushang Property Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Lushang Property Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 7.65B | 8.29B | 8.82B | 10.3B | 13.6B | 12.4B | 13.0B | 4.58B | 3.98B | 3.65B | 3.70B |
| Gross Profit | 1.12B | 1.54B | 1.78B | 2.16B | 2.76B | 2.98B | 2.93B | 2.12B | 2.09B | 1.93B | 2.07B |
| Operating Income | 224M | 349M | 471M | 574M | 875M | 678M | 311M | 419M | 338M | 208M | 170M |
| EBITDA | 263M | 414M | 550M | 499M | 852M | 730M | 692M | 364M | 308M | 399M | 214M |
| Net Income | 92.4M | 128M | 162M | 345M | 639M | 362M | 45.5M | 303M | 244M | 188M | 148M |
| EPS | 0.09 | 0.13 | 0.16 | 0.34 | 0.63 | 0.35 | 0.04 | 0.30 | 0.24 | 0.18 | 0.15 |
| Balance Sheet | |||||||||||
| Total Assets | 42.5B | 43.4B | 48.9B | 56.0B | 61.5B | 61.4B | 58.5B | 7.82B | 6.00B | 5.86B | 5.76B |
| Total Liabilities | 40.0B | 40.8B | 46.0B | 51.3B | 55.0B | 54.9B | 52.9B | 3.14B | 1.21B | 910M | 744M |
| Shareholders' Equity | 2.23B | 2.33B | 2.44B | 2.74B | 4.08B | 4.73B | 3.72B | 4.01B | 4.10B | 4.23B | 4.29B |
| Cash & Short-term Investments | 4.24B | 2.56B | 3.83B | 3.63B | 5.07B | 5.14B | 4.32B | 1.73B | 2.95B | 2.90B | 2.76B |
| Total Debt | 11.8B | 10.1B | 9.60B | 10.7B | 11.5B | 9.29B | 7.73B | 2.18B | 264M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.47B | 1.56B | 2.10B | -3.31B | 4.45B | 6.85B | 998M | 537M | 229M | 276M | - |
| Capital Expenditure | 25.4M | 23.0M | 33.7M | 60.2M | 157M | 282M | 166M | 211M | 157M | 110M | 92.7M |
| Free Cash Flow | -2.49B | 1.53B | 2.06B | -3.37B | 4.29B | 6.57B | 832M | 263M | 71.4M | 166M | -36.2M |
| Ratios | |||||||||||
| ROE | 4.1% | 5.5% | 6.6% | 12.6% | 15.7% | 7.7% | 1.2% | 7.6% | 5.9% | 4.4% | 3.5% |
| ROA | 0.2% | 0.3% | 0.3% | 0.6% | 1.0% | 0.6% | 0.1% | 3.9% | 4.1% | 3.2% | 2.6% |
| Net Profit Margin | 1.2% | 1.5% | 1.8% | 3.3% | 4.7% | 2.9% | 0.4% | 6.6% | 6.1% | 5.1% | 4.0% |
| Debt to Equity | 5.30x | 4.34x | 3.94x | 3.89x | 2.81x | 1.96x | 2.08x | 0.54x | 0.06x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Lushang Property Co Ltd dividends
- Dividend yield
- 1.18%
- Forward dividend
- 0.06 CNY
- Payout ratio
- 34.7%
- Ex-dividend date
- Jul 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 65.2M | 0.06 | 34.7% |
| 2024 | CNY 184M | 0.18 | 75.4% |
| 2023 | CNY 488M | 0.48 | 160.8% |
| 2022 | CNY 111M | 0.10 | 244.2% |
| 2021 | CNY 202M | 0.20 | 55.8% |
| 2020 | CNY 110M | 0.11 | 17.2% |
| 2019 | CNY 50.0M | 0.05 | 14.5% |
| 2018 | CNY 738M | 0.73 | 455.5% |
| 2017 | CNY 635M | 0.65 | 496.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 12.5:10 on Feb 20, 2006.
Who owns Lushang Property Co Ltd
- Insiders 57.65%
- Institutions 0.54%
- Public & others 41.81%
- Shares outstanding 1.02B
- Free float 475M
Lushang Property Co Ltd company profile
- Company name
- Lushang Property Co Ltd
- Ticker
- 600223.SHG
- ISIN
- CNE000001147
- Exchange
- Shanghai Stock Exchange
- Listed since
- Sep 13, 1999
- Sector
- Consumer Defensive
- Industry
- Real Estate Management & Development
- Employees
- 3,514
- Fiscal year end
- December
- Address
- No. 888, High-tech Zone, Jinan, China, 250101
- Phone
- 86 53 1812 13217
- Website
- lshfreda.com
About Lushang Property Co Ltd
Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant extracts, chemical synthesis, tablets, capsules, drinks, injections, granules, and other products. The company offers its products through online and offline channels. It exports its products to North America, the European Union, Japan, South Korea, and Southeast Asia. The company was formerly known as Lushang Health Industry Development Co.,Ltd. and changed its name to Lushang Freda Pharmaceutical Co.,Ltd. in April 2023. The company was founded in 1993 and is based in Jinan, China. Lushang Freda Pharmaceutical Co.,Ltd. is a subsidiary of Shandong Commercial Group Co.,Ltd.
Lushang Property Co Ltd management
5- Mr. Baiqiang XuFinancial Director · born 1977
- Mr. Deqiang ZhengDeputy General Manager · born 1978
- Mr. Chunming GaoDeputy General Manager · born 1968
- Ai Min YangAccounting Supervisor
- Ms. Xixi DouDeputy GM & Board Secretary · born 1982